United KingdomThe article discusses the author's personal experience with societal pressure to conform to increasingly slim body standards, driven by the popularity of GLP-1 medications like Wegovy and Mounjaro. The author notes that many people around them are using these drugs to lose weight quickly, creating a sense of 'FOMO' (fear of missing out) on body transformation. While the author does not judge others for taking the medication, they express frustration at feeling left out of the trend and envy of the rapid results seen in others. The author explains their own gradual weight loss through diet and exercise, despite challenges related to a hypothyroidism diagnosis and midlife metabolism changes. They ultimately choose not to take GLP-1 due to cost concerns and a preference for natural methods.
Bias read (Center): While the article touches on societal beauty standards and health trends, it does not present a clear ideological stance. The author expresses personal feelings about body image and weight loss but avoids overtly criticizing either the use of GLP-1 drugs or the broader cultural shift toward slimness
%2C%2520el%252022%2520de%2520julio%2520de%25202026&w=3840&q=75&output=webp&we)
